Researchers continue to excited about the medication , a novel dual compound showing significant outcomes in clinical trials for body loss . It acts by targeting two pathways : GLP-1 and GIP, which , when https://xandertltk854936.blogunteer.com/39534168/the-new-prospect-for-weight-management